Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-046811

Chief Business Officer acquired 1,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2023-09-01 Grant or award +500 $33.10 $16,550 20,529 D
Robb Gary Charles Chief Business Officer 2023-09-01 Grant or award +500 21,029 D
Loading xslF345X05/ownership.xml…